On Air Now

Current Show

WSAU Wisconsin Morning News   5:00 AM - 8:00 AM

Seth Mela, Tom King and Chris Conley

Show Info »

Upcoming Shows

Program Schedule »

Listen

Listen Live Now » 550 AM Wausau, WI 99.9 FM Stevens Point, WI

Weather

Current Conditions(Wausau,WI 54403)

More Weather »
57° Feels Like: 57°
Wind: NNW 6 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

PM Thunderstorms 77°

Tonight

Thunderstorms Early 52°

Tomorrow

Partly Cloudy 76°

Alerts

Bayer's regorafenib gets priority review by FDA

FRANKFURT (Reuters) - U.S. health regulators granted a priority review for Bayer's cancer drug regorafenib for the treatment of gastrointestinal stromal tumors, potentially speeding up the treatment's route to market.

The U.S. Food and Drug Administration grants priority reviews to medicines that are considered potentially significant therapeutic advancements over existing therapies.

A priority review takes six months rather than the usual 10 to 12-months.

Onyx Pharmaceuticals is the U.S. marketing partner for regorafenib, which will be branded as Stivarga.

(Reporting by Ludwig Burger)

Comments